- Home
- CMRE vs PCRX Comparison
CMRE vs PCRX Comparison
Compare CMRE & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRE
- PCRX
- Stock Information
- Founded
- CMRE 1974
- PCRX 2006
- Country
- CMRE Monaco
- PCRX United States
- Employees
- CMRE N/A
- PCRX N/A
- Industry
- CMRE Marine Transportation
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- CMRE Consumer Discretionary
- PCRX Health Care
- Exchange
- CMRE Nasdaq
- PCRX Nasdaq
- Market Cap
- CMRE 1.0B
- PCRX 1.2B
- IPO Year
- CMRE 2010
- PCRX 2011
- Fundamental
- Price
- CMRE $8.87
- PCRX $25.25
- Analyst Decision
- CMRE Hold
- PCRX Buy
- Analyst Count
- CMRE 2
- PCRX 9
- Target Price
- CMRE $13.50
- PCRX $30.11
- AVG Volume (30 Days)
- CMRE 594.3K
- PCRX 979.9K
- Earning Date
- CMRE 05-09-2025
- PCRX 05-06-2025
- Dividend Yield
- CMRE 5.19%
- PCRX N/A
- EPS Growth
- CMRE N/A
- PCRX N/A
- EPS
- CMRE 2.44
- PCRX N/A
- Revenue
- CMRE $2,083,894,000.00
- PCRX $700,966,000.00
- Revenue This Year
- CMRE N/A
- PCRX $9.48
- Revenue Next Year
- CMRE N/A
- PCRX $11.31
- P/E Ratio
- CMRE $3.48
- PCRX N/A
- Revenue Growth
- CMRE 37.88
- PCRX 3.85
- 52 Week Low
- CMRE $8.11
- PCRX $11.16
- 52 Week High
- CMRE $17.58
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- CMRE 42.11
- PCRX 57.66
- Support Level
- CMRE $8.29
- PCRX $24.10
- Resistance Level
- CMRE $9.13
- PCRX $26.73
- Average True Range (ATR)
- CMRE 0.42
- PCRX 1.51
- MACD
- CMRE -0.00
- PCRX 0.14
- Stochastic Oscillator
- CMRE 41.48
- PCRX 73.50
About CMRE Costamare Inc. $0.0001 par value
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.